ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddys launches migraine management wearable device Nerivio in Germany
Dr. Reddy's Laboratories announced the launch of the drug-free non-invasive migraine management wearable device Nerivio in Germany through its step-down subsidiary betapharm. The launch marks the company's entry into digital therapeutics in Europe. Nerivio
Announcement as on 10 April 2024

Dr Reddys and Bayer partner to market and distribute second brand of Vericiguat in India
Under the terms of this agreement, Bayer has granted non-exclusive rights to Dr. Reddy's under the brand name Gantra.
Announcement as on 05 April 2024

Buy Dr Reddy’s Laboratories; target of Rs 6537: Sharekhan
Sharekhan is bullish on Dr Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 6537 in its research report dated April 01, 2024.
Announcement as on 02 April 2024

Dr Reddy's rises on distribution partnership with Sanofi Healthcare
Dr Reddy's Laboratories gained 1.93% to Rs 6164.10 after the company said that it has entered into an exclusive partnership with Sanofi Healthcare India (SHIPL) to promote and distribute SHIPL vaccine brands across private markets in India.
Announcement as on 28 March 2024

Dr Reddy’s gains on distribution tie-up with Sanofi Healthcare
Dr Reddy’s Laboratories | A meeting of the board of directors of the company will be held on Tuesday, May 7, 2024, to consider and approve the audited standalone and consolidated financial results of the company.
Announcement as on 28 March 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 14.79
  • 12Day Average: 14.16
  • 20Day Average: 13.8
  • 50Day Average: 13.59
  • 100Day Average: 13.75
  • 150Day Average: 13.76
  • 200Day Average: 13.85

RDY Indicators & signals

Indicator MACD (12,26,9)

14.25, 13.93, 0.25
Indicator MACD is in positive zone

Indicator ADX (14)

3.23, 41.03, 38.46
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 1.04 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 1 times
29 Mon Jun 2026 14.86 14.66 to 15.13 -3.38% 1.56 times
26 Fri Jun 2026 15.38 15.30 to 15.67 0.85% 1.09 times
25 Thu Jun 2026 15.25 14.61 to 15.27 4.02% 1.36 times
24 Wed Jun 2026 14.66 14.20 to 14.66 2.45% 0.92 times
23 Tue Jun 2026 14.31 13.80 to 14.31 2.88% 1.22 times
22 Mon Jun 2026 13.91 13.45 to 14.03 4.67% 0.95 times
18 Thu Jun 2026 13.29 13.20 to 13.36 1.06% 0.59 times
17 Wed Jun 2026 13.15 13.08 to 13.32 -1.13% 0.85 times
16 Tue Jun 2026 13.30 13.23 to 13.38 -0.23% 0.47 times
15 Mon Jun 2026 13.33 13.32 to 13.43 0.23% 0.3 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top